Vanguard realigns reporting; Axogen (NASDAQ: AXGN) shows 0 shares owned
Rhea-AI Filing Summary
The Vanguard Group files an amendment to Schedule 13G disclosing zero beneficial ownership of Axogen Inc common stock. The filing states an amount beneficially owned: 0 and percent of class: 0%. It explains an internal realignment adopted on 01/12/2026 that prompted disaggregated reporting by certain Vanguard subsidiaries.
Positive
- None.
Negative
- None.
Insights
Vanguard disaggregated holdings and reports no beneficial ownership of Axogen common stock.
The filing lists amount beneficially owned: 0 and percent of class: 0%, reflecting reporting changes after an internal realignment dated 01/12/2026. This is a reporting adjustment rather than a market trade.
Cash-flow treatment and any prior holdings are not stated in the excerpt; subsequent filings may provide additional ownership detail.
Amendment shows disaggregated reporting by Vanguard entities under SEC Release No. 34-39538.
The amendment explains that certain subsidiaries will report separately and that Vanguard "no longer has, or is deemed to have, beneficial ownership" over those subsidiaries' securities per the cited SEC release.
This is a procedural disclosure about beneficial ownership attribution; it does not by itself indicate a change in Axogen's governance or capital structure.
FAQ
What did The Vanguard Group report for AXGN in this Schedule 13G/A amendment?
Why does Vanguard say it now reports holdings separately for AXGN?
Who signed the Schedule 13G/A amendment for Vanguard regarding AXGN?